Search

everythinglearnresearchcommunity

for

Search:↓

Patients with hidradenitis suppurativa have higher levels of cell-free DNA in their blood.

The study identified key immune cell differences between mild and severe alopecia areata.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Adding hair restoration to a cosmetic surgery practice requires a skilled team and specialized equipment.

Hedgehog signaling controls hair follicle development and can affect skin cancer growth.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

SQSTM1 is linked to increased risk of alopecia areata.

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

Higher CRHR1 levels in AA patients lead to increased inflammation.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

HGF-modified hair follicle stem cells help brain recovery after injury in rats.

Patients with central centrifugal cicatricial alopecia benefit from shared decision-making with their doctors.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Multiparametric ultrasound is a useful non-invasive tool for assessing scalp conditions in alopecia areata patients.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

The ISHRS received high-level approval for its educational programs.